生命科学资讯

Ukko eyes clinic with UKK-0018 for peanut allergy

Other news to note for Jan. 8, 2026

Regulatory actions for Jan. 8, 2026

Inflarx focuses on izicopan as biopharma spending cuts continue

Moonlake preps for sonelokimab BLA in HS; no new trials needed

FDA rejects Vanda’s Hetlioz for jet lag disorder

Ventyx’s NLRP3 inhibitors best in class? Lilly offers $1.2B

Appeals court says no to cap on indirect costs in NIH grants

Hetero Labs describes new tyrosine kinase inhibitors

New 3CLpro inhibitors disclosed in Nxera Pharma patent

Shanghai Huilun Pharmaceutical discovers new 5-HT2A receptor agonists

Appointments and advancements for Jan. 7, 2026

Financings for Jan. 7, 2026

In the clinic for Jan. 7, 2026

Other news to note for Jan. 7, 2026

Regulatory actions for Jan. 7, 2026

AI drug discovery brings $2B+ Sanofi deal to 1-year-old Earendil

New TNFR1 antagonists disclosed in Dana-Farber Cancer Institute patent

Chinese scientists discover new GTPase KRAS mutant inhibitors

Holiday notice